PharmaCyte Biotech, Inc. cotiza a 0.36 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulatio…
| Periodo | 2022-09 | 2022-07 | 2022-03 | 2021-12 |
|---|---|---|---|---|
| Real | $-0.07 | $-0.06 | $-0.04 | $-0.06 |
| Estimado | $-0.07 | $-0.04 | $-0.05 | $-0.07 |
| Sorpresa | +0.0% | -50.0% | +20.0% | +14.3% |
| Métrica | PMCB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -58.3% | -40.4% | -17.9% |
| ROA | -41.5% | -32.0% | -9.5% |
| Current Ratio | 45.28 | 2.84 | +42.44 |
| Debt / Equity | — | 0.28 | — |